西妥昔单抗
医学
内科学
胰腺癌
危险系数
肿瘤科
荟萃分析
随机对照试验
优势比
置信区间
辅助治疗
癌症
无进展生存期
结直肠癌
化疗
作者
Tobias Förster,Felix J. Huettner,Christoph Springfeld,Matthias Loehr,Eva Kalkum,Matthes Hackbusch,Thilo Hackert,Markus K. Diener,Pascal Probst
出处
期刊:Oncology
[Karger Publishers]
日期:2019-10-02
卷期号:98 (1): 53-60
被引量:35
摘要
In the presence of no survival benefit, increased toxicity, and higher costs, a decreased cost-benefit ratio compared to the standard care must be suggested. Conducting further RCTs in unselected pancreatic cancer populations is unlikely to change this conclusion.
科研通智能强力驱动
Strongly Powered by AbleSci AI